EGFR and non-small cell lung carcinoma: Recent studies have found that proviral integration site for Moloney murine leukemia virus 1 (PIM1) kinase promotes EMT-related osimertinib resistance in EGFR-mutated NSCLC by modulating the glycogen synthase kinase-3β (GSK3β) signaling pathway.